Fresenius Medical Care Reports Strong Adjusted Q1 Profit Growth, Completes EUR 1B Share Buyback
FMS is trading near its 52-week low of $20.945 (3.4% above the low).
Summary
Fresenius Medical Care AG reported strong adjusted operating income and EPS growth for Q1 2026, alongside a significant increase in cash flow and the successful completion of its EUR 1 billion share buyback program.
Key Events · Earnings and Guidance · FMS
-
Strong Adjusted Q1 Performance
Adjusted operating income grew 10% and adjusted EPS increased by 16% at constant currency, indicating solid underlying business health despite reported declines.
-
Significant Cash Flow Improvement
Operating cash flow increased by 39% to EUR 227 million, and free cash flow surged by 94% to EUR 40 million, demonstrating improved liquidity.
-
EUR 1 Billion Share Buyback Completed
The company successfully concluded its EUR 1.0 billion share buyback program on April 30, repurchasing 8.5% of its share capital, which supported EPS growth.
-
FME25+ Transformation Progress
The program delivered EUR 50 million in additional sustainable savings in Q1, though it incurred EUR 166 million in one-time costs, primarily from clinic closures.
Analysis · FMS · Industrial Applications And Services
The company's first-quarter results present a mixed picture, with reported revenue and net income declining due to unfavorable currency effects and one-time costs from its FME25+ transformation program. However, adjusted figures, which exclude these special items, demonstrate solid operational performance with a 10% increase in operating income and 16% growth in EPS at constant currency. The significant improvement in operating and free cash flow, coupled with the successful completion of the EUR 1 billion share buyback program, provides a positive signal to investors, especially as the stock trades near its 52-week low. The confirmation of the full-year 2026 outlook suggests management confidence in continued execution of its FME Reignite strategy despite ongoing transformation efforts.
At the time of this filing, FMS was trading at $21.66 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $20.95 to $30.46. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.